FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: DETERMINATION THAT STRATTERA (ATOMOXETINE HYDROCHLORIDE) CAPSULES 5 MILLIGRAMS, 10 MILLIGRAMS, 18 MILLIGRAMS, 25 MILLIGRAMS, 40 MILLIGRAMS, 60 MILLIGRAMS, 80 MILLIGRAMS, AND 100 MILLIGRAMS, WERE NOT WITHDRAWN FROM SALE FOR REASONS OF SAFETY OR EFFECTIVENESS

WASHINGTON, April 6 -- Food and Drug Administration has issued a notice called: Determination That STRATTERA (Atomoxetine Hydrochloride) Capsules 5 Milligrams, 10 Milligrams, 18 Milligrams, 25 Milligrams, 40 Milligrams, 60 Milligrams, 80 Milligrams, and 100 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness.

The notice was published in the Federal Register on April 6 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA or Agency) has determined that STRATTERA (atomoxetine hydrochloride) capsules 5 milligrams, 10 milligrams, 18 Milligrams, 25 Milligrams, 40 Milligrams, 60 Milligrams, 80 Milligrams, and 100 Milligrams, were not...